P3 Health PartnersPIII
13F holders, Q3 2025 (September 30)14holders −1
1new positions
2sold out
$9.00avg. 13F price*
At the end of Q3 2025, 14 institutions reported holding P3 Health Partners Inc. (PIII) in their 13F filings, down 1 from Q2 2025. 1 opened new positions and 2 sold out. The largest holders were Alyeska Investment Group, L.P. ($1.6M), Vanguard Group Inc. ($447K) and Corient Private Wealth LP ($316K).
- Company
- P3 Health Partners Inc.
- CUSIP
- 744413204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $590 |
| Exits | 2 | $3K |
All 13F filers, Q2 2025 → Q3 2025: 11,260 shares bought and 2,111 shares sold, net +9,149 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| Alyeska Investment Group, L.P. | 0.00% | No change | 180,906 | $1.6M |
| Vanguard Group Inc. | 0.00% | Add +27.0% | 48,716 | $447K |
| Corient Private Wealth LP | 0.00% | No change | 35,369 | $316K |
| Geode Capital Management, LLC | 0.00% | Add +0.8% | 20,377 | $187K |
| BlackRock, Inc. | 0.00% | Reduce -0.4% | 10,539 | $94K |
| Blair William & Co. | 0.00% | Add +27.4% | 3,096 | $28K |
| PNC Financial Services Group, Inc. | 0.00% | No change | 1,373 | $12K |
| JPMorgan Chase & Co. | 0.00% | No change | 1,019 | $9K |
| UBS Group AG | 0.00% | Reduce -91.7% | 134 | $1K |
| BNP Paribas Financial Markets | 0.00% | Reduce -68.0% | 80 | $716 |
| Barclays PLC | 0.00% | New | 66 | $590 |
| FMR LLC | 0.00% | Add +100.0% | 4 | $37 |
| Bank of America Corp. | 0.00% | Reduce -93.8% | 1 | $9 |
| Royal Bank of Canada | 0.00% | No change | 2 | $0 |
"% of holder's portfolio" is PIII's weight in each manager's 13F, not the share of P3 Health Partners Inc. the manager owns.